Repeated High-dose Inhaled Corticosteroids for Asthma
| Status: | Withdrawn |
|---|---|
| Conditions: | Asthma |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 50 |
| Updated: | 5/10/2018 |
| Start Date: | May 2008 |
| End Date: | September 2011 |
The purpose of this study is to to compare the effects of high-dose Inhaled Corticosteroids
(ICS) vs. placebo in adults with chronic stable asthma.
(ICS) vs. placebo in adults with chronic stable asthma.
Inclusion criteria:
- Physician diagnosis of asthma.
- Age ≥18 years and ≤50 years
- Evidence of airflow obstruction as measured by spirometry and flow-volume loop per
American Thoracic Society guidelines.
- Treatment for asthma with:
- daily inhaled corticosteroids and long-acting beta2-agonists, AND
- as-needed use of a short-acting beta2-agonist
Exclusion criteria:
- History of >10 pack-year tobacco use
- Other pulmonary or cardiac diagnosis that is actively being treated
- History of adverse events or allergy to fluticasone
- Systemic corticosteroid therapy within 7 days of study visit
- Inability to obtain written informed consent
We found this trial at
1
site
University of Chicago One of the world's premier academic and research institutions, the University of...
Click here to add this to my saved trials